For the drugs we need

Herbert Jack Rotfeld (Auburn University, Auburn, Alabama, USA)

Journal of Consumer Marketing

ISSN: 0736-3761

Publication date: 1 December 2005

Abstract

Purpose

To delineate confusions and uncertainties of the issues surrounding those criticisms. Critics assert that all marketing of medical products is abusive, while actual impacts are disputed.

Design/methodology/approach

Pulling from past commentaries on pharmaceutical marketing and current criticisms of the practice, to indicate areas of confusion.

Findings

The ills of pharmaceutical marketing are not as great as critics presume, but the practices are not as positive as the companies might wish to assert. With uncertainty on the actual impact of specific practices, the companies are engaging in a certain degree of warfare via ever‐increasing budgets of sometimes‐questionable value.

Practical implications

Puts criticisms of pharmaceutical marketing in context.

Originality/value

Perspectives for understanding pharmaceutical marketing.

Keywords

Citation

Rotfeld, H. (2005), "For the drugs we need", Journal of Consumer Marketing, Vol. 22 No. 7, pp. 365-368. https://doi.org/10.1108/07363760510631093

Download as .RIS

Publisher

:

Emerald Group Publishing Limited

Copyright © 2005, Emerald Group Publishing Limited

Please note you might not have access to this content

You may be able to access this content by login via Shibboleth, Open Athens or with your Emerald account.
If you would like to contact us about accessing this content, click the button and fill out the form.
To rent this content from Deepdyve, please click the button.